<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Seventeen articles describing 231 COVID-19 patients with rheumatic diseases were found during the literature search (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>) [
 <xref ref-type="bibr" rid="CR27">27</xref>–
 <xref ref-type="bibr" rid="CR43">43</xref>]. Among these patients, there was only one pediatric patient who was a 6-month-old infant with Kawasaki disease and COVID-19 [
 <xref ref-type="bibr" rid="CR31">31</xref>]. The characteristics of the patients are presented in Table 
 <xref rid="Tab1" ref-type="table">1</xref>. 77.5% of the patients were female (
 <italic>n</italic> = 179). The most common underlying rheumatic diseases were systemic lupus erythematosus (SLE) (
 <italic>n</italic> = 117) and rheumatoid arthritis (RA) (
 <italic>n</italic> = 45). Nine out of 231 (3.9%) patients died. Of note, Konig et al. did not report outcomes with regard to mortality in their COVID-19 cohort, including 80 SLE patients [
 <xref ref-type="bibr" rid="CR41">41</xref>].
</p>
